COMMUNIQUÉS West-GlobeNewswire

Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders

12/03/2018 - 01:00

Board of Directors Recommends Removal of Terminated CEO Joseph Payne from Board of Directors SAN DIEGO, March 11, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (Arcturus or the Company) (NASDAQ: ARCT ), an RNA [...]

Immutep Raises A$6.85m Through Institutional Placement

12/03/2018 - 00:55

A$6.85m raised through share institutional placement to drive immuno-oncology development programs Placement of new ordinary shares to leading Australian healthcare institutional investors Platinum Asset Management and [...]

Immutep Enters Into Clinical Trial Collaboration and Supply Agreement With MSD

12/03/2018 - 00:25

SYDNEY, Australia, March 11, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”) has announced that it has entered into a clinical trial collaboration and supply agreement [...]

Clinical Trials Show Strong Long-Term Performance with the Medtronic CoreValve TAVR System

10/03/2018 - 18:16

Presented at ACC.18, Five-Year Follow-up from the CoreValve Extreme Risk and NOTION Studies Show Sustained Valve Function and Durability Over Time DUBLIN and ORLANDO - March 10, 2018 - Medtronic plc (NYSE: MDT) today [...]

Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need

10/03/2018 - 15:03

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce plans to make Praluent ® more accessible and affordable for patients with the greatest health risk and unmet need Precision medicine [...]

Sanofi et Regeneron annoncent leurs plans pour rendre Praluent® plus facilement accessible et économiquement abordable aux patients à risque élevé présentant d'importants besoins non satisfaits

10/03/2018 - 15:03

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Regeneron annoncent leurs plans pour rendre Praluent ® plus facilement accessible et économiquement abordable aux patients à risque élevé [...]

Sanofi: Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate

10/03/2018 - 15:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Praluent ® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate ODYSSEY OUTCOMES trial [...]

Sanofi : Praluent® (alirocumab) a significativement réduit le risque d'événements cardiovasculaires chez des patients à risque élevé, et a été associé à une réduction du taux de mortalité

10/03/2018 - 15:01

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Praluent ® (alirocumab) a significativement réduit le risque d'événements cardiovasculaires chez des patients à risque élevé, et a été associé à une [...]

SuperSonic Imagine Vows To Vigorously Defend Against Intellectual Property Lawsuit

09/03/2018 - 23:53

AIX-EN-PROVENCE, France, March 09, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specialised in medical imaging using ultrasound, said today that it strongly denies allegations [...]

BioStem Technologies Inc. Enter into Agreement with Barbara Krutchkoff, PhD. To Guide Scientific Affairs

09/03/2018 - 23:09

Pompano Beach, FL, March 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration in [...]

Profound Medical to Release Fourth Quarter and Full Year 2017 Financial Results on March 26, 2018 – Conference Call to Follow

09/03/2018 - 22:45

TORONTO, March 09, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to offer a therapeutic platform that provides the precision of real-time MR [...]

R1 RCM to Present at the Cowen and Company 38th Annual Health Care Conference

09/03/2018 - 20:41

CHICAGO, March 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced that its management team will [...]

Nova Leap Health Corp. Reports Fourth Quarter and Full Year 2017 Financial Results

09/03/2018 - 20:33

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, March 09, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) (“Nova Leap” or “the Company”), a [...]

Spring Bank to Present at Cowen & Company 38th Annual Health Care Conference

09/03/2018 - 20:19

HOPKINTON, Mass., March 09, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company

09/03/2018 - 18:01

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

09/03/2018 - 18:01

Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

Antares Pharma to Present at the Cowen and Company 38th Annual Healthcare Conference

09/03/2018 - 18:00

EWING, N.J., March 09, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 38 th Annual [...]

Daxor Corporation Announces Positive New Critical Care Research Highlighting Benefit from BVA Use; Daxor Corporation to Exhibit at the American College of Cardiology 2018 Annual Meeting (NYSE MKT LLC: DXR)

09/03/2018 - 17:55

New York, NY, March 09, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an investment company with medical instrumentation and biotechnology operations, exhibited at the 2018 Society for Critical Care [...]

Medtronic EVP & CFO Karen Parkhill to Speak at Barclays Healthcare Conference

09/03/2018 - 17:01

DUBLIN - March 9, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will answer questions about the company on Wednesday, March 14, 2018, in Miami, Florida. Karen Parkhill, [...]